- Pediatric Critical Care and COVID19, Sebastián González-Dambrauskas etal, Pediatrics 2020
- IMPACT OF GLUCOCORTICOID TREATMENT IN SARS-COV-2 INFECTION MORTALITY: A RETROSPECTIVE CONTROLLED COHORT STUDY-Ana Fernández Cruz, etal. AAC 2020
- Audio Interview: New Data on Remdesivir in Covid-19 – Rubin EJ, et al. N Engl J Med, 2020.
- Audio Interview: New Data on Remdesivir in Covid-19 – Rubin EJ, et al. N Engl J Med, 2020.
- COVID-19 Treatment Guidelines – National Institutes of Health
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial – Wang Y, et al. Lancet, 2020
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. Geleris J, et al. N Engl J Med, 2020
- Guidelines on the Treatment and Management of Patients with COVID-19 – Infectious Diseases Society of America
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review – Sanders JM, et al. JAMA, 2020.
- Assessment of Evidence for COVID-19-Related Treatments – American Society of Health-System Pharmacists
- Registered clinical trials for COVID-19 – National Institutes of Health
- Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease – has not received enough attention till date– Sieni E, et al. Br J Haematol, 2020
- A real-time dashboard of clinical trials for COVID-19 – Thorlund K, et al. Lancet Digit Health, 2020
- Randomized Clinical Trials and COVID-19: Managing Expectations – Bauchner H, et al. JAMA, 2020